<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01324284</url>
  </required_header>
  <id_info>
    <org_study_id>AIG-GI2011-01</org_study_id>
    <nct_id>NCT01324284</nct_id>
  </id_info>
  <brief_title>Comparative Study of Lubiprostone and PEG Preparation Versus Conventional PEG Preparation for Colonoscopy</brief_title>
  <acronym>Lubiprostone</acronym>
  <official_title>Comparative Study of Lubiprostone and PEG Preparation Versus Conventional PEG Preparation to Enhance the Colonoscopy Preparation Quality in an Indian Tertiary Care Center.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asian Institute of Gastroenterology, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asian Institute of Gastroenterology, India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lubiprostone as an adjunct to the standard bowel preparation regime the quality of bowel
      preparation can be improved for a good colonoscopic examination without missing lesions and
      complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

        1. Primary:

             -  Same day Low volume PEG with placebo (Arm 1) versus same day low volume PEG with
                Lubiprostone (Arm 2)

             -  Waiting time for colonoscopic procedure and quality of bowel preparation

        2. Secondary:

             -  Quality of bowel preparation without Dietary restriction (Modified bowel
                preparation regime without Fiber diet restrictions)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of bowel preparation in Same day Low volume PEG with placebo versus same day low volume PEG with Lubiprostone</measure>
    <time_frame>2 months</time_frame>
    <description>Quality of bowel preparation is based on Boston Bowel Preparation Score (BBPS)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">442</enrollment>
  <condition>Colorectal Carcinoma</condition>
  <arm_group>
    <arm_group_label>Lubiprostone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lubiprostone with PEG solution versus Placebo with PEG solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lubiprostone versus placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lubiprostone</intervention_name>
    <description>Lubiprostone is a chloride channel activator approved by the Food and Drug Administration for the treatment of chronic constipation. A randomized, double-blind, parallel-group, placebo-controlled study evaluating the effect of lubiprostone on gastric function showed slowed gastric emptying and increased small bowel and colonic transit time. Peak plasma concentration was shown to be around 1.14 hours, with a majority of the drug excreted in the urine within 48 hours.</description>
    <arm_group_label>Lubiprostone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. All adult patient referred for colonoscopy to AIG

          2. Age 18 - 75 years old

        Exclusion Criteria:

          1. Acute GI bleeding.

          2. Patient of bowel preparation regime other than excepted for the study.

          3. Renal insufficiency.

          4. Dementia.

          5. Symptomatic heart failure.

          6. Recent Myocardial Infarction.

          7. Patients with ileus.

          8. Suspected bowel obstruction.

          9. Prior alimentary tract surgery.

         10. Significant gastroparesis.

         11. Gastric outlet obstruction.

         12. Toxic colitis or megacolon.

         13. Pregnant or lactating patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nageshwar D Reddy, MD. DM</last_name>
    <role>Study Director</role>
    <affiliation>Asian Institute of Gastroenterolgy India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rupa Banerjee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asian Institute of Gastroenterology, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Saravanan Arjunan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asian Institute of Gastroenterology, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manu Tandan, MD DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>AIG Hyderabad india</affiliation>
  </overall_official>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2011</study_first_submitted>
  <study_first_submitted_qc>March 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2011</study_first_posted>
  <last_update_submitted>April 4, 2013</last_update_submitted>
  <last_update_submitted_qc>April 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asian Institute of Gastroenterology, India</investigator_affiliation>
    <investigator_full_name>Rupa Banerjee</investigator_full_name>
    <investigator_title>Consultant gastroenterologist</investigator_title>
  </responsible_party>
  <keyword>Lubiprostone</keyword>
  <keyword>Bowel preparation regime</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lubiprostone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

